Could a One-Time methadone shot during hip surgery cut painkiller dependence?
NCT ID NCT07227064
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving a single intravenous dose of methadone during hip replacement surgery reduces pain and the need for extra opioids right after the operation. Researchers will compare pain scores and opioid use in 162 adults receiving either methadone or a placebo. The goal is to see if this simple addition improves recovery and lowers opioid consumption.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- methadone
- What this could lead to
- If it works, this could offer a simple way to better manage pain after hip replacement and reduce the need for other opioids.
- What could go wrong
- This is a single-center trial with 162 people, so results may not apply broadly. Methadone can cause side effects like nausea or breathing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 162 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion * Ages 18-75 years of age * Undergoing elective primary total hip arthroplasty with mepivacaine in the spinal anesthesia Exclusion * Allergy to methadone or mepivacaine * Severe liver disease defined as Child's Pugh Class C * End stage renal disease requiring dialysis * Known diagnosis of prolonged QT syndrome * Currently pregnant * Unable to provide written, informed consent * Non-English speaking
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Post operative pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pre-surgery paracetamol and tramadol combo beat fentanyl for day-case pain?
- Two nerve blocks go head to head for hip replacement pain
- Insulin eye drops put to the test for faster corneal healing
- Can a Longer-Lasting nerve block cut opioid use after spine surgery?
- Could a simple mineral calm the Body's Post-Surgery fire?
- Nanoparticle cleaning may calm pain after failed root canals in diabetic patients